US and French medical imaging firms join
Bio-Imaging Technologies has bought French imaging firm Theralys as
it strives to broaden its clinical trial medical imaging service
PPD sales rise as CRO sector stays buoyant
PPD saw its sales rise 17 per cent in the fourth quarter, fuelled
by its large Development segment.
Averion jumps on the Indian CRO bandwagon
US-based Averion has signed a deal with an Indian contract research
organisation (CRO) to offer combined services to pharma and biotech
ICON, Phase Forward, etrials ink eclinical deals
ICON Clinical Research has teamed up with Phase Forward while
etrials has scored 10 new contracts in the latest stage of the
Covance steps up Chinese presence
US outsourcing company Covance has announced it is to open a
central laboratory in China in order to meet the growing demand for
clinical trials conducted in the region and has expanded its
capabilities in Texas.
Clinical contract news in brief
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract research world last week.
Medifacts in troubled waters
Medifacts International has this week filed for Chapter 11
bankruptcy protection amidst plans to sell off its clinical
research services division.
'Unanticipated problems' in trials must be reported, says HHS
The Department of Health and Human Services (HHS) has released
updated guidelines on clinical trial reporting requirements in the
Hesperion turns to Russia to tackle large trials
Hesperion has opened a Russian arm of its contract research
business in a bid to 'increase its attractiveness' to clinical
trial sponsors requiring large patient populations.
Parexel reports impressive profit
Parexel has announced encouraging financial results for its second
fiscal quarter, despite 'disappointing' performance in its medical
PRA enters large-scale alliance with US Oncology
PRA International has entered into an alliance with US Oncology
Research, designed to accelerate the clinical development of new
cancer treatments in the US.
Charles River knuckles down on preclinical biz
Charles River Laboratories confirmed it is persevering in its
intention to focus on its preclinical and Phase I businesses while
abandoning its late stage development services, during a conference
earlier this month.
Outsourcing favoured for Phase IV research
Regardless of internal capacity, the majority of pharma firms are
choosing to outsource their Phase IV research.
Electronic wave set to benefit clinical trials
The move towards electronic files is set to bring major benefits in
the clinical trials area especially in terms of patient
recruitment, new research suggests.
Clinical trials globalisation strengthens Parexel
There are currently three key market trends that play to Parexel's
strengths and one of them is the globalisation of clinical trials,
the company's CEO claimed during a healthcare conference earlier